Word

BIOPHARM INSIGHT

Status

Dead

Status Code

606

Status Date

Monday, January 15, 2018

Serial Number

86315630

Mark Type

3000

Filing Date

Friday, June 20, 2014

Published for Opposition

Tuesday, October 20, 2015

Abandoned Date

Monday, January 15, 2018

Trademark Owner History

Mergermarket Limited - Owner At Publication

Classifications

9 Electronic publications, namely, reports, books and newsletters in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning recorded on computer media; digital media and recordings, namely, pre-recorded DVDs, downloadable audio and video recordings, and CDs in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; electronic books in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning recorded on computer media; downloadable electronic publications in the nature of reports, books and newsletters in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; downloadable digital media and recordings namely, electronic video recordings in the fields of biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; Downloadable electronic data files featuring data in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; computer software for desktop publishing

35 Advertising services; business management; business administration services and managing office functions in the nature database management for others; business information management services; business consultancy services; business management and organisation consultancy services; provision of business and commercial information for the academic and scientific, and professional and business communities in the fields of biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; business research services; commercial information agency services; provision of statistical information for business and commercial purposes in the field of business investments, mergers and acquisitions; conducting public opinion polling services; conducting market opinion polling studies; compilation and systemisation of information into computer databases; computerised file managing; document reproduction; arranging newspapers and magazine subscriptions for others; news clipping services; publication of publicity texts; marketing research and marketing research studies; arranging and conducting exhibitions, conferences, congresses, conventions and trade shows for business and commercial purposes; data retrieval services, namely, providing an on-line searchable database featuring business information and commercial information; business information and advisory services; research and analysis in the fields of economics; providing business information and business news relating to business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs industry, biotechnology medical products industry, biotherapeutics industry, and biologicals and related research and development industries; preparing financial reports for others; preparing financial reports for others via the Internet, telecommunication and other electronic communication networks; providing information and news in the fields of mergers and acquisitions of corporations

36 Financial advice and consultancy services; financial research, analysis, forecasting and advisory services; financial information; financial information relating to mergers, acquisitions, corporate transactions, debt finance, debt trading and debt issuance; debt collection services; financial information evaluation, appraisal, forecasting and reporting; financial analysis; financial research services; financial information and financial advisory services; financial advice and consultancy services provided online via the Internet, telecommunication and other electronic communication networks; financial research, analysis, forecasting and advisory services provided online via the Internet, telecommunication and other electronic communication networks; financial information provided online via the Internet, telecommunication and other electronic communication networks; financial information relating to mergers, acquisitions, corporate transactions, debt finance, debt trading and debt issuance provided online via the Internet, telecommunication and other electronic communication networks; debt collection services provided online via the Internet, telecommunication and other electronic communication networks; financial information evaluation, appraisal, forecasting and reporting provided online via the Internet, telecommunication and other electronic communication networks; financial analysis provided online via the Internet, telecommunication and other electronic communication networks; financial research services provided online via the Internet, telecommunication and other electronic communication networks; financial information and financial advisory services provided online via the Internet, telecommunication and other electronic communication networks; providing information and news in the fields of corporate financial transactions, debt finance, debt trading, debt issuance, investment advice on biotechnology drugs, investment advice on biotechnology medical products, investment advice on biotherapeutics and investment advice on biologicals and related research and development companies, investment strategies for high net worth individuals, and financial retirement planning; providing financial information and financial news relating to business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs industry, biotechnology medical products industry, biotherapeutics industry, and biologicals and related research and development industries, investment strategies for high net worth individuals, and retirement planning

41 Education services, namely, providing of training in the fields of business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; arranging and conducting seminars in the fields of business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; library services provided by means of a computer database which feature on-line newspapers, magazines, photographs and pictures via an on-line computer network; publication of reports, books and newsletters in the field of financial information, financial reports and financial analysis

42 Providing scientific information and related research and development information in the fields of biotechnology drugs, biotechnology medical products, biotherapeutics, and biologicals

Color is not claimed as a feature of the mark.
"BIOPHARM"
The mark consists of a design of four squares with two squares on top and two on the bottom linked by four lines and placed to the left of the mark "BioPharm Insight".

Trademark Events

Jan 16, 2018

Abandonment Notice Mailed - No Use Statement Filed

Jan 15, 2018

Abandonment - No Use Statement Filed

Dec 4, 2017

Applicant/Correspondence Changes (Non-Responsive) Entered

Dec 4, 2017

Teas Change Of Owner Address Received

Dec 4, 2017

Attorney/Dom.Rep.Revoked And/Or Appointed

Dec 4, 2017

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jun 17, 2017

Notice Of Approval Of Extension Request E-Mailed

Jun 15, 2017

Extension 3 Granted

Jun 15, 2017

Extension 3 Filed

Jun 15, 2017

Teas Extension Received

Dec 17, 2016

Notice Of Approval Of Extension Request E-Mailed

Dec 15, 2016

Extension 2 Granted

Dec 15, 2016

Extension 2 Filed

Dec 15, 2016

Teas Extension Received

Jul 22, 2016

Notice Of Approval Of Extension Request E-Mailed

Jul 21, 2016

Extension 1 Granted

Jun 14, 2016

Extension 1 Filed

Jul 20, 2016

Case Assigned To Intent To Use Paralegal

Jun 14, 2016

Teas Extension Received

Dec 15, 2015

Noa E-Mailed - Sou Required From Applicant

Oct 20, 2015

Official Gazette Publication Confirmation E-Mailed

Oct 20, 2015

Published For Opposition

Sep 30, 2015

Notification Of Notice Of Publication E-Mailed

Sep 14, 2015

Law Office Publication Review Completed

Sep 8, 2015

Approved For Pub - Principal Register

Jul 11, 2015

Teas/Email Correspondence Entered

Jul 10, 2015

Correspondence Received In Law Office

Jul 10, 2015

Teas Response To Office Action Received

May 22, 2015

Notification Of Non-Final Action E-Mailed

May 22, 2015

Non-Final Action E-Mailed

May 22, 2015

Non-Final Action Written

May 8, 2015

Previous Allowance Count Withdrawn

May 5, 2015

Withdrawn From Pub - Og Review Query

Apr 17, 2015

Law Office Publication Review Completed

Apr 15, 2015

Approved For Pub - Principal Register

Mar 31, 2015

Teas/Email Correspondence Entered

Mar 31, 2015

Correspondence Received In Law Office

Mar 31, 2015

Teas Request For Reconsideration Received

Feb 3, 2015

Notification Of Final Refusal Emailed

Feb 3, 2015

Final Refusal E-Mailed

Feb 3, 2015

Final Refusal Written

Dec 30, 2014

Teas/Email Correspondence Entered

Dec 30, 2014

Correspondence Received In Law Office

Dec 30, 2014

Assigned To Lie

Dec 17, 2014

Assigned To Lie

Dec 9, 2014

Teas Response To Office Action Received

Oct 9, 2014

Notification Of Non-Final Action E-Mailed

Oct 9, 2014

Non-Final Action E-Mailed

Oct 9, 2014

Non-Final Action Written

Sep 29, 2014

Assigned To Examiner

Jun 28, 2014

Notice Of Design Search Code E-Mailed

Jun 27, 2014

New Application Office Supplied Data Entered In Tram

Jun 24, 2014

New Application Entered In Tram